Biomedical Odyssey

Life at the Johns Hopkins School of Medicine

A gloved hand holds a dengue vaccine vial.

The Dengue Vaccine Controversy Explained

July 9, 2019

Dengue, a virus endemic to Latin America and Southeast Asia, infects about 400 million people and causes about 25,000 deaths each year by dengue hemorrhagic fever (DHF). To date there is no cure for dengue, and its toll hits hardest in areas with poorly developed medical systems. Due to the deadly consequences of this virus, […]

Talia Henkle ⋅ Perspectives in Research dengue, FDA, infectious disease, Vaccine ⋅

Scientist removes a test tube. Gloved hand. Light blue tint applied to image.

Advancing the Manufacturing of Human Cell and Gene Therapies

September 11, 2018

Cellular and gene therapy-related research in the United States is growing at a fast pace, with many products moving forward in clinical development. Applications of these cellular and gene therapies range from using a person’s own cells and genetically altering them to fight cancer, to replacing a gene in the eye to restore vision in […]

Yazmin Rovira Gonzalez ⋅ Events and Happenings CASSS, cellular research, conference, Conference Networking, FDA, gene therapy, gene therapy products ⋅

Once-Daily Combination Pills Offer More Than Convenience

February 15, 2016

In November 2015, the FDA approved the HIV-1 medication Genvoya, a once-daily pill containing fixed doses of the HIV drugs elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide. This is the latest once-daily medication to be produced to treat HIV, a disease that used to be managed primarily with many different pills taken multiple times a day. […]

Arielle Medford ⋅ Perspectives in Research FDA, HIV, medication ⋅

Legislative Bill Prompts Discussion of Cross-Talk in the Scientific Community

July 31, 2015

Earlier this month, the U.S. House of Representatives approved a bill directly impacting the biomedical research community. If approved by the Senate, the 21st Century Cures Act promises to increase the budget of the National Institutes of Health (NIH) and provide it with an additional $8.75 billion over the next five years. The Food and […]

Arielle Medford ⋅ Perspectives in Research 21st Century Cures Act, Bill, Biomedical Research, cfDNA, Cross-Talk, FDA, Food and Drug Administration, House of Representatives, National Institutes of Health, NIH, Noninvasive Prenatal Testing ⋅

Subscribe to the Blog

Introduction

  • About This Blog
  • Meet the Authors
  • Do You Want to Write for Us?

Blog Categories

  • A Day in the Life
  • Events and Happenings
  • Honor Roll
  • Perspectives in Research

More About the School of Medicine

  • Johns Hopkins University School of Medicine
  • Life at Hopkins
  • Training at Johns Hopkins School of Medicine

Archives